UBS, the Swiss financial services group, is facing civil charges from the Securities and Exchange Commission over possible violations relating to work its investment bank carried out for HealthSouth, the US healthcare group.
HealthSouth is subject to a $4.5bn (€3.36bn) accounting fraud investigation.